![Kevin Shaw](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Shaw
Conseiller Juridique Général chez
NEXTCURE, INC.
Profil
Kevin G.
Shaw is currently General Counsel at NextCure, Inc. since 2023.
Formerly, Mr. Shaw was Vice President & Deputy General Counsel at Precigen, Inc. from 2012 to 2022.
Education includes undergraduate studies at the University of Pennsylvania and graduate studies at George Washington University Law School.
Postes actifs de Kevin Shaw
| Sociétés | Poste | Début |
|---|---|---|
| NEXTCURE, INC. | Conseiller Juridique Général | 01/05/2022 |
Anciens postes connus de Kevin Shaw
| Sociétés | Poste | Fin |
|---|---|---|
| PRECIGEN, INC. | Corporate Officer/Principal | 01/05/2022 |
Formation de Kevin Shaw
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
36
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Precigen, Inc.
 Precigen, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
George Washington University Law School
 George Washington University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
